2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top AnalystsThe Motley Fool • 08/03/25
Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatePRNewsWire • 07/23/25
Viking Therapeutics Gears Up for Q2 Earnings: Here's What to ExpectZacks Investment Research • 07/21/25
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?The Motley Fool • 07/20/25
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.The Motley Fool • 07/19/25
Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025PRNewsWire • 07/16/25
Viking Therapeutics: What's Next After GLP-1 Hype Dies Down And Competition IntensifiesSeeking Alpha • 07/10/25
Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In ObesityInvestors Business Daily • 06/25/25